BNET Industries

ThermoGenesis Corp.

is in the Manufacturing Industry

Last Fiscal Year Sales:$21.9M
  • Private
  • US
Dow Jones Description

ThermoGenesis is committed to developing innovative, enabling technologies that address the Blood Processing and Hospital/Wound Care markets of the healthcare industry, while improving patient outcomes and shareholder value. ThermoGenesis provides Healthcare professionals with the means to micro-manufacture potentially life-saving and life-enhancing products from individual units of blood. An ISO-certified company focused on the needs of our customers and their patients, we are dedicated to the continuous improvement of product quality and services. ThermoGenesis dedicates extensive research to the development of technology platforms. These platforms provide unique systems to facilitate the production of therapeutically valuable biological products from single units of blood. For example, umbilical cord blood banks utilize our BioArchive System as a critical enabling technology for cryopreserving and archiving stem cell units for transplant. Our CryoSeal FS System is used to prepare autologous hemostatic and adhesive surgical sealants from patient blood in approximately an hour. Moreover, since 1992, ThermoGenesis has been a leading supplier of state-of-the-art blood component Thawing Systems and Plasma Freezing Systems to hospitals and blood banks.

Number of Employees 90
Contact Information

2711 Citrus Road

Rancho Cordova, California 95742

thermogenesis.c...

(916) 858-5100

NAICS Code : 339111

Recent Events

  • ThermoGenesis loss is reason for optimism

    11/06/09 - Financial Announcement - View Story

  • ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer EXECUTIVE HAS MORE...

    10/19/09 - Mgmt. Change Entering - Vice President - View Story

  • ThermoGenesis Appoints Jorge Artiles As VP, Chief Quality And Regulatory Affairs Officer - Quick Facts

    10/19/09 - Mgmt. Change Entering - Legal - View Story

  • ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer

    10/19/09 - Mgmt. Change Entering - Vice President - View Story

  • ThermoGenesis faces delisting from Nasdaq

    9/21/09 - Financial Announcement - View Story

  • Gentium loses CEO, board

    8/12/09 - Mgmt. Change Entering - Vice President - View Story

  • Automated Medical Device quickly processes bone marrow.

    8/18/09 - Product Announcement - View Story

News & Analysis

thermogenesis corp. - All News and Analysis

advertisement
advertisement